Latest Raising News

Page 20 of 1424
Ocean Sciences has secured firm commitments for a $700,000 placement to fund its Indonesian seaweed operations, innovation centre and research pipeline. The raising comes with a substantial package of options, while a further loyalty offer could add to the company’s future capital structure.
Victor Sage
Victor Sage
4 Nov 2026
Torque Metals has extended high-grade mineralisation beyond the current resource at HHH, including a 1.1-metre interval grading 89.64 g/t gold. The ASX-listed explorer is now preparing to add a third rig after completing a $25 million capital raising.
Maxwell Dee
Maxwell Dee
4 Nov 2026
Northstone Resources has entered voluntary suspension while it finalises a proposed capital raising, with an announcement expected by 5 November 2026. The size, pricing, structure and potential dilution remain undisclosed.
Victor Sage
Victor Sage
4 Nov 2026
Scentre Group has reaffirmed its 2026 funds-from-operations and distribution targets after reporting stronger visitation, sales and leasing metrics across its Westfield portfolio. Exposure to David Jones remains material in floor space but limited in earnings terms, with rent paid through September.
Eva Park
Eva Park
4 Nov 2026
Arbitr Group has proposed a A$4.86 million capital raising to fund an organisational reset and push into enterprise AI, while warning that non-participating shareholders could face about 43% dilution. The plan also targets A$2 million in recurring annual cost savings and a calendar 2026 release for its Enterprise AI Context Engine.
Sophie Babbage
Sophie Babbage
4 Nov 2026
Felix Gold has secured $7.25 million in placement commitments at a 14.3% discount and will seek a further $1 million from eligible shareholders. The funds will support mine permitting, refinery studies, drilling and resource work, but part of the raise still requires shareholder approval.
Maxwell Dee
Maxwell Dee
4 Nov 2026
BOA Resources has completed its maiden 46-hole RC program at Ricci Lee with high-grade copper results across two lodes, including a 23-metre intersection at 2.65% copper. The mineralisation remains open at depth and to the north, with diamond drilling planned to begin in November.
Maxwell Dee
Maxwell Dee
4 Nov 2026
Cynata Therapeutics has completed its $912,962 entitlement offer and secured firm commitments for a further $550,000 placement. The second raise still requires shareholder approval and will bring additional shares and options into an already heavily funded capital structure.
Ada Torres
Ada Torres
4 Nov 2026
Ingenia Communities has told ASX it found no evidence that directors, executives or advisers disclosed confidential takeover information before market announcements. The company remains unable to explain how details of competing AVID and Warburg Pincus proposals appeared in media reports ahead of release.
Eva Park
Eva Park
4 Nov 2026
Radiopharm Theranostics has reached final alignment with the U.S. FDA on a single pivotal Phase 3 trial for RAD101, its brain metastases imaging agent. The approximately 280-patient study is expected to begin dosing in the first half of 2027, moving the program from regulatory planning towards execution.
Ada Torres
Ada Torres
4 Nov 2026
Percheron Therapeutics has lodged a prospectus for up to 280 million options linked to its earlier $2.3 million placement, with the securities carrying a $0.01 exercise price and expiring in April 2028. The filing raises no meaningful cash on issue, but could provide up to $2.8 million if all options are later exercised while adding a potentially dilutive layer to the capital structure.
Victor Sage
Victor Sage
4 Nov 2026
Supermicro’s preliminary fiscal first-quarter sales nearly quadrupled year on year to US$19.9 billion, as net income reached US$1.59 billion. The company forecast fiscal 2027 revenue of US$72 billion to US$82 billion, although weaker sequential margins and negative operating cash flow add important qualifications.
Sophie Babbage
Sophie Babbage
4 Nov 2026

Browse the archive

Full archive